An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

Abstract The advent of dose intensified interval compressed therapy has improved event-free survival for patients with localized Ewing sarcoma (EwS) to 78% at 5 years. However, nearly a quarter of patients with localized tumors and 60–80% of patients with metastatic tumors suffer relapse and die of...

Full description

Bibliographic Details
Main Authors: David S. Shulman, Sarah B. Whittle, Didier Surdez, Kelly M. Bailey, Enrique de Álava, Jason T. Yustein, Adam Shlien, Masanori Hayashi, Alexander J. R. Bishop, Brian D. Crompton, Steven G. DuBois, Neerav Shukla, Patrick J. Leavey, Stephen L. Lessnick, Heinrich Kovar, Olivier Delattre, Thomas G. P. Grünewald, Cristina R. Antonescu, Ryan D. Roberts, Jeffrey A. Toretsky, Franck Tirode, Richard Gorlick, Katherine A. Janeway, Damon Reed, Elizabeth R. Lawlor, Patrick J. Grohar
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-022-00307-2

Internet

https://doi.org/10.1038/s41698-022-00307-2

Similar Items